Last updated on March 2020

Study Evaluating Safety Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)


Find a site near you

Start Over

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
3.73miles
  Connect »

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
3.73miles
  Connect »

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
3.73miles
  Connect »

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
3.73miles
  Connect »

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
3.73miles
  Connect »

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
4.12miles
  Connect »

GSK Investigational Site

Pozuelo De Alarcón/Madrid, Spain
4.12miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.